Regeneron Pharmaceuticals (REGN)
Net Income
$1.95B
Quarterly · Period ending: · USD
REGN Net Income
Latest reported$1.95Bperiod ending
Latest reported$1.95Bperiod ending
REGN Quarterly Net Income (-$800.00K → $1.95B)
Quarterly net income
High-resolution chart · PNG
REGN net income history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income (USD) |
|---|---|
| -19,931,000 | |
| -14,834,000 | |
| -13,037,000 | |
| -9,739,000 | |
| -3,211,000 | |
| -2,947,000 | |
| -7,318,000 | |
| -1,400,000 | |
| -4,900,000 | |
| -7,800,000 | |
| -8,900,000 | |
| -5,500,000 | |
| -1,400,000 | |
| 2,100,000 | |
| -3,800,000 | |
| 500,000 | |
| -1,900,000 | |
| -4,300,000 | |
| -5,900,000 | |
| -8,100,000 | |
| -8,900,000 | |
| -7,600,000 | |
| -7,800,000 | |
| -7,800,000 | |
| -7,100,000 | |
| -4,400,000 | |
| -4,200,000 | |
| -5,800,000 | |
| -4,000,000 | |
| -10,200,000 | |
| -10,700,000 | |
| -11,500,000 | |
| -9,600,000 | |
| -9,400,000 | |
| -9,300,000 | |
| -6,400,000 | |
| -5,800,000 | |
| -3,700,000 | |
| -3,300,000 | |
| -2,100,000 | |
| -900,000 | |
| -300,000 | |
| -1,100,000 | |
| -900,000 | |
| -800,000 | |
| -800,000 | |
| -800,000 |